INTERACTIONS BETWEEN ELLIPTICINE AND SOME DERIVATIVES AND PHOSPHOLIPIDS IN MODEL MEMBRANES

被引：18

作者：

ELMASHAK, EM ^{[1
]}

PAOLETTI, C ^{[1
]}

TOCANNE, JF ^{[1
]}

机构：

[1] CNRS,PHARMACOL & TOXICOL FONDAMENTALES LAB,F-31078 TOULOUSE,FRANCE

来源：

FEBS LETTERS | 1979年 / 107卷 / 01期

关键词：

D O I：

10.1016/0014-5793(79)80485-8

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

[No abstract available]

引用

收藏

页码：155 / 159

页数：5

相关论文

共 22 条

[1] CHADWICK M, 1978, DRUG METAB DISPOS, V6, P528
[2] MONOLAYER STUDY OF THE ADSORPTION OF METHYL-LYSINE AT PHOSPHATIDYLGLYCEROL-WATER INTERFACES - MODEL FOR ELUCIDATING THE CONFORMATION OF THE LYSYLPHOSPHATIDYLGLYCEROL POLAR HEAD
ELMASHAK, EM
TOCANNE, JF
[J]. JOURNAL OF COLLOID AND INTERFACE SCIENCE, 1979, 70 (01) : 56 - 66
[3] NEW DNA INTERCALATING DRUG - METHOXY-9-ELLIPTICINE
FESTY, B
POISSON, J
PAOLETTI, C
[J]. FEBS LETTERS, 1971, 17 (02): : 321 - +
[4] GUENTHNER TM, BIOCH PHARMACOL
[5] HANSCH C, 1972, CANCER CHEMOTH REP 1, V56, P433
[6] JURET P, 1979, NOUV PRESSE MED, V8, P1495
[7] KELLNER BMJ, 1979, CHEM PHYS LIPIDS, V23, P41, DOI 10.1016/0009-3084(79)90021-5
[8] NEW ANTITUMORAL AGENT - 9-HYDROXYELLIPTICINE - POSSIBILITY OF A RATIONAL DESIGN OF ANTI-CANCEROUS DRUGS IN SERIES OF DNA INTERCALATING DRUGS
LEPECQ, JB
NGUYENDANGHUNG
GOSSE, C
PAOLETTI, C
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1974, 71 (12) : 5078 - 5082
[9] ELLIPTICINES AS POTENT INHIBITORS OF ARYL-HYDROCARBON HYDROXYLASE - THEIR BINDING TO MICROSOMAL CYTOCHROMES P450 AND PROTECTIVE EFFECT AGAINST BENZO(A)PYRENE MUTAGENICITY
LESCA, P
LECOINTE, P
PAOLETTI, C
MANSUY, D
[J]. BIOCHEMICAL PHARMACOLOGY, 1978, 27 (08) : 1203 - 1209
[10] HYDROXYLATION OF ANTI-TUMOR AGENT, ELLIPTICINE, BY LIVER-MICROSOMES FROM DIFFERENTLY PRETREATED RATS
LESCA, P
LECOINTE, P
PAOLETTI, C
MANSUY, D
[J]. BIOCHEMICAL PHARMACOLOGY, 1977, 26 (22) : 2169 - 2173